您的位置: 首页 > 农业专利 > 详情页

Acylaminocycloalkyl compounds suitable for treating disorders that respond to modulation of dopamine D3 receptor
专利权人:
AbbVie Inc.;AbbVie Deutschland GmbH & Co. KG
发明人:
Haupt, Andreas,Dinges, Jurgen,Unger, Liliane,Wicke, Karsten,Van Waterschoot, Robert,Drescher, Karla,Relo, Ana Lucia
申请号:
AU2014230215
公开号:
AU2014230215A1
申请日:
2014.03.14
申请国别(地区):
AU
年份:
2015
代理人:
摘要:
The present invention relates to novel acylaminocycloalkyl compounds, in particular to the compounds of the formula I as described herein and to their salts and N-oxides. The compounds possess valuable therapeutic properties and are suitable, in particular, for treating diseases that respond to modulation of the dopamine D3 receptor. In formula I, the variables have the following meanings: m is 1 or 2, n is 1 or 2, A is selected from the group consisting of CH
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充